Biological
NDV-HXP-S COVID-19 vaccine clinical trials
How studies write it
Studies that test it under each name
Name
- NDV-HXP-S 10μg
- 2
Studies by the year they started
3 studies that test it; most in 2021 (2)
| Year | Studies |
|---|---|
| 2021 | 2 |
| 2023 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 0 · Other 3
Butantan Institute (2) · Mahidol University (1)
Studies
Open first, then newest update. How each study uses NDV-HXP-S COVID-19 vaccine is read from its arms, and is right about nine times in ten.
Testing it · 3
- Phase II/III Randomized Clinical Trial of Booster Dose of COVID-19 (Recombinant, Inactivated) VaccineCompletedPhase 2/3Butantan InstituteNCT05354024Written as NDV-HXP-S 10μg
- Clinical Trial of the COVID-19 Vaccine (Recombinant, Inactivated) in BrazilCompletedPhase 1Butantan InstituteNCT04993209Written as NDV-HXP-S 1μg
- Assess the Safety and Immunogenicity of NDV-HXP-S Vaccine in ThailandCompletedPhase 1/2Mahidol UniversityNCT04764422Written as NDV-HXP-S vaccine